Wanru Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wanru Liang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Feiyang Yang
Jilin University, Changchun, Jilin, China
1 shared publication Peihong Teng
Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun, China
1 shared publication- Tianyang Zhang
Department of General Surgery Center Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, China
1 shared publication - Wei-Zhang Shen
Department of Hematology and Oncology, The Second Hospital of Jilin University, Changchun, China
1 shared publication
Latest Publications
- Open Access
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Recent advances in deep learning for lymphoma segmentation: Clinical applications and challenges
Lymphoma is a prevalent malignant tumor within the hematological system, posing significant challenges to clinical practice due to its diverse subtypes, intricate radiological and metabolic manifestations. Lymphoma segmentation studies based on positron emission tomography/computed tomography (PET/CT), CT, and magnetic resonance imaging represent key strategies for addressing these challenges. This article reviews the advancements in lymphoma segmentation research utilizing deep learning methods, offering a comparative analysis with traditional approaches, and conducting an in-depth examination and summary of aspects such as dataset characteristics, backbone networks of models, adjustments to network structures based on research objectives, and model performance. The article also explores the potential and challenges of translating deep learning-based lymphoma segmentation research into clinical scenarios, with a focus on practical clinical applications. The future research priorities in lymphoma segmentation are identified as enhancing the models’ clinical generalizability, integrating into clinical workflows, reducing computational demands, and expanding high-quality datasets. These efforts aim to facilitate the broad application of deep learning in the diagnosis and treatment monitoring of lymphoma.
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Open AccessRecent advances in deep learning for lymphoma segmentation: Clinical applications and challenges
Lymphoma is a prevalent malignant tumor within the hematological system, posing significant challenges to clinical practice due to its diverse subtypes, intricate radiological and metabolic manifestations. Lymphoma segmentation studies based on positron emission tomography/computed tomography (PET/CT), CT, and magnetic resonance imaging represent key strategies for addressing these challenges. This article reviews the advancements in lymphoma segmentation research utilizing deep learning methods, offering a comparative analysis with traditional approaches, and conducting an in-depth examination and summary of aspects such as dataset characteristics, backbone networks of models, adjustments to network structures based on research objectives, and model performance. The article also explores the potential and challenges of translating deep learning-based lymphoma segmentation research into clinical scenarios, with a focus on practical clinical applications. The future research priorities in lymphoma segmentation are identified as enhancing the models’ clinical generalizability, integrating into clinical workflows, reducing computational demands, and expanding high-quality datasets. These efforts aim to facilitate the broad application of deep learning in the diagnosis and treatment monitoring of lymphoma.